MENGENAI EPISOD INI

Bahasa Inggeris
Amerika Syarikat

Tunjukkan NOTA 🔗

TRANSKRIP 🔗

CARI EPISOD LEPAS

Cari episod lepas bagi VJDementia Podcast.

EPISOD LAIN DALAM PODCAST INI

On January 6, 2023, the US FDA approved lecanemab for the treatment of Alzheimer’s disease (AD), making history as the first ever treatment to significantly slow cognitive decline. Despite the excitement surrounding this breakthrough approval, concerns remain regarding the extent of lecanemab's ...
In today’s episode, we hear from top researchers studying the retina as a window to the Alzheimer's brain. Hear the latest on retinal biomarkers, the development of a diagnostic 'eye test' for Alzheimer's disease, and the promise of retina organoids for novel drug development.  With Frederique ...
Welcome to the VJSounds podcast, presented by the Video Journal of Dementia. In this episode, we dive into the latest advancements in Alzheimer's disease (AD) biomarkers, focusing on the diagnostic and predictive potential of plasma p-tau217. As an alternative to traditional PET assessment, blo ...
In this episode, VJDementia are joined by Amy Lloyd, PhD, Soyon Hong, PhD, João Pedro Ferrari-Souza, MD-PhD student, & Elina Svensson, PhD student, who share their work looking at the roles of microglia in health and disease, and the implications of this for understanding how to treat Alzhei ...
Penafian: Podcast dan karya seni yang dibenamkan pada halaman ini adalah daripada vjdementia, yang merupakan hak milik pemiliknya dan tidak bergabung dengan atau disokong oleh Listen Notes, Inc.